Access Pharmaceuticals, Inc. Stock OTC Bulletin Board
Stocks
ACCP
US00431M3088
Pharmaceuticals
|
End-of-day quote
OTC Bulletin Board
|
||
| - USD | - |
|
| Market Cap | 300M 264M 250M 226M 426M 28.79B 432M 3B 1.15B 14.72B 1.13B 1.1B 47.18B | P/E 2026 * |
-5.34x | P/E 2027 * | -26.3x |
|---|---|---|---|---|---|
| Enterprise Value | 300M 264M 250M 226M 426M 28.79B 432M 3B 1.15B 14.72B 1.13B 1.1B 47.18B | EV / Sales 2026 * |
5.7x | EV / Sales 2027 * | 2.6x |
| Free-Float |
84.73% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Access Pharmaceuticals, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Vishwas Seshadri
CEO | Chief Executive Officer | 50 | 2021-10-14 |
Joseph Vazzano
DFI | Director of Finance/CFO | 42 | 2022-03-13 |
James A. Gow
CTO | Chief Tech/Sci/R&D Officer | - | 2025-10-19 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Alvino
BRD | Director/Board Member | 58 | 2006-02-28 |
Faith Charles
BRD | Director/Board Member | 64 | 2021-03-24 |
Leila Alland
BRD | Director/Board Member | 63 | 2021-04-18 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.33% | +0.53% | +51.65% | +115.42% | 1,056B | |
| -1.06% | -1.65% | +42.78% | +69.98% | 645B | |
| -0.65% | -1.32% | +12.98% | +75.49% | 465B | |
| -2.66% | -1.87% | +73.13% | +41.15% | 368B | |
| -0.06% | -3.88% | +34.32% | +39.39% | 335B | |
| -0.79% | +2.01% | +19.82% | +27.79% | 275B | |
| -1.19% | -1.21% | +9.82% | +10.61% | 255B | |
| -0.50% | +3.80% | +49.37% | +56.84% | 229B | |
| -1.47% | -1.53% | +34.28% | +98.89% | 188B | |
| Average | -0.84% | -0.18% | +36.46% | +59.51% | 423.98B | |
| Weighted average by Cap. | -1.02% | -0.23% | +39.91% | +71.39% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 52.63M 46.35M 43.91M 39.64M 74.72M 5.05B 75.68M 525M 202M 2.58B 198M 193M 8.27B | 116M 102M 96.47M 87.09M 164M 11.09B 166M 1.15B 444M 5.67B 434M 425M 18.17B |
| Net income | -56.16M -49.46M -46.86M -42.3M -79.73M -5.39B -80.76M -561M -216M -2.75B -211M -206M -8.83B | -11.39M -10.03M -9.5M -8.58M -16.17M -1.09B -16.37M -114M -43.74M -558M -42.76M -41.82M -1.79B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- ABEO Stock
- ACCP Stock
Select your edition
All financial news and data tailored to specific country editions
